Servier to buy Day One Biopharmaceuticals for total equity value of $2.5 billion
06/03/2026 13:34
March 6 (Reuters) - Independent international pharmaceutical group Servier will buy Day One Biopharmaceuticals DAWN.O for a total equity value of about $2.5 billion, the companies said on Friday. (Reporting by Christy Santhosh in Bengaluru) ((Christy.Santhosh@thomsonreuters.com;))